We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRI
701
DELISTED
Everi Holdings
EVRI
$1.98M 0.01%
92,831
-69,974
-43% -$1.59M
DNZ.U
702
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
$1.98M 0.01%
200,000
FVIV.U
703
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
$1.98M 0.01%
200,000
TSPQ.U
704
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$1.98M 0.01%
200,000
NTLA icon
705
Intellia Therapeutics
NTLA
$1.52B
$1.98M 0.01%
16,721
-8,204
-33% -$1.03M
ARWR icon
706
Arrowhead Research
ARWR
$12.1B
$1.96M 0.01%
+29,571
New +$2.03M
LCAHU
707
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$1.96M 0.01%
195,940
-304,060
-61% -$3.05M
VAQC
708
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$1.95M 0.01%
200,000
WHD icon
709
Cactus
WHD
$3.69B
$1.94M 0.01%
+50,879
New +$2.05M
EOCW.U
710
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$1.93M 0.01%
192,912
-57,088
-23% -$574K
AEHR icon
711
Aehr Test Systems
AEHR
$2.28B
$1.93M 0.01%
+79,699
New +$1.56M
FRTA
712
DELISTED
Forterra, Inc
FRTA
$1.92M 0.01%
80,660
+15,660
+24% +$373K
ROCC
713
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.87M 0.01%
+69,628
New +$2.05M
AMX icon
714
America Movil
AMX
$77.2B
$1.83M 0.01%
86,500
BILL icon
715
BILL Holdings
BILL
$4.62B
$1.82M 0.01%
7,310
-4,868
-40% -$1.38M
APYX icon
716
Apyx Medical
APYX
$163M
$1.78M 0.01%
138,699
-3,876
-3% -$54.2K
ESACU
717
DELISTED
ESGEN Acquisition Corporation Unit
ESACU
$1.77M 0.01%
+175,000
New +$1.77M
OGN icon
718
Organon & Co
OGN
$3.55B
$1.76M 0.01%
57,820
+2,238
+4% +$72.9K
JWSM.U
719
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$1.75M 0.01%
175,000
CSL icon
720
Carlisle Companies
CSL
$14.1B
$1.75M 0.01%
+7,056
New +$1.62M
NET icon
721
Cloudflare
NET
$93.7B
$1.71M 0.01%
13,020
-8,260
-39% -$1.38M
SAVE
722
DELISTED
Spirit Airlines, Inc.
SAVE
$1.7M 0.01%
77,686
-5,100
-6% -$118K
ZUO
723
DELISTED
Zuora, Inc.
ZUO
$1.68M 0.01%
+90,088
New +$1.81M
FACT.U
724
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
$1.67M 0.01%
170,000
INFY icon
725
Infosys
INFY
$50B
$1.67M 0.01%
65,876

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.